Streetbeat News

Analyst Ratings

BP

Redburn Atlantic analyst Peter Low has downgraded BP from Buy to Neutral, indicating a shift in the analyst's outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:16 am

KVUE

RBC Capital has downgraded Kenvue (NYSE:KVUE) from Outperform to Sector Perform, setting a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:13 am

DIDIY

Macquarie analyst Ellie Jiang has initiated coverage on DiDi Global (OTC:DIDIY) with an Outperform rating and set a price target of $5.5.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:09 am

DAY

Keybanc analyst Jason Celino has initiated coverage on Dayforce (NYSE:DAY) with an Overweight rating and set a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:06 am

BIDU

HSBC analyst Charlene Liu has downgraded Baidu from Buy to Hold, setting a price target of $100.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:03 am

PTGX

TD Cowen has initiated coverage on Protagonist Therapeutics with a Buy rating and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:55 am

BRZE

Needham analyst Scott Berg has reiterated a Buy rating on Braze (NASDAQ:BRZE) and maintained a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:50 am

AAPL

Needham analyst Laura Martin has reiterated a Buy rating on Apple (NASDAQ:AAPL) and maintained a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:46 am

CLFD

Needham analyst Ryan Koontz has reiterated a Buy rating on Clearfield (NASDAQ:CLFD) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:41 am

HRMY

Needham analyst Ami Fadia has reiterated a Buy rating on Harmony Biosciences (NASDAQ:HRMY) and maintained a price target of $52.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:30 am